Articles Tagged With: immunogenicity
-
Adjuvanted Recombinant Hepatitis B Vaccine (Heplisav-B)
Heplisav-B is a new hepatitis B vaccine approved by the FDA in November 2017.
Browse by Speciality Area
All Access Subscription
Get unlimited access to our full publication and article library.
Get Access NowInterested in Group Sales? Learn more
Heplisav-B is a new hepatitis B vaccine approved by the FDA in November 2017.